Dysfunctional cGMP/GC-C signaling has been implicated in compromised epithelial barrier function, increased intestinal inflammation and tumor growth (23), accelerating the progression of gastrointestinal disorders such as IBD and colon carcinoma (24,25). The gene discussed is GUCY2C; the disease is inflammatory bowel disease.